Tenet Healthcare Corp director Roy Blunt reported selling 600 shares of Common Stock on 2026-08-05 at a weighted average price of $262.68 per share, executed in multiple trades between $262.52 and $262.70. After this sale, he directly holds 4,589 shares.
Tammy Romo filed to sell 2,500 shares of common stock through Fidelity Brokerage Services LLC on August 7, 2026 under Rule 144. The shares, with an aggregate market value of $652,062.50, were originally acquired via restricted stock vesting as compensation on May 8, 2018. Over the prior three months, Romo sold 4,922 shares for total proceeds of $1,300,146.30.
THC reports a planned sale of 4,922 shares of common stock through Fidelity Brokerage Services LLC on or after August 6, 2026 on the NYSE. The shares have an aggregate market value of $1,300,146.30, while 80,519,000 shares were outstanding. The stock to be sold comes from restricted stock vesting awards of 3,836 shares on May 9, 2025 and 1,086 shares on May 23, 2025.
FMR LLC and Abigail P. Johnson report updated beneficial ownership of Tenet Healthcare Corp common stock on a Schedule 13G/A. FMR LLC reports beneficial ownership of 3,994,545.39 shares, representing 4.6% of the common stock outstanding, with sole dispositive power over this entire amount and sole voting power over 3,985,108.16 shares.
The filing states that this represents ownership of 5 percent or less of the class. One or more other persons have rights to receive dividends or sale proceeds from these securities, but no such person holds more than five percent of Tenet Healthcare’s total outstanding common stock. Subsidiary-level details are provided in an attached Exhibit 99.
Tenet Healthcare Corp executive vice president and chief operating officer Lisa Y. Foo reported selling 10,000 shares of Common Stock on 2026-07-29 in an open-market transaction at a weighted average price of $258.03 per share, based on multiple trades between $257.97 and $258.43.
After this sale, Foo directly holds 32,053 shares of Tenet Healthcare Common Stock. The Rule 10b5-1 trading-plan checkbox was not marked, and the insider has undertaken to provide detailed trade-by-trade pricing information upon request to the company, its security holders, or SEC staff.
Tenet Healthcare Corporation reported higher profitability for the quarter ended June 30, 2026. Net operating revenues rose to $5,628 million from $5,271 million, and operating income increased to $1,501 million from $823 million, helped by solid volume growth in both Hospital Operations and Ambulatory Care.
Results were also boosted by $413 million of revenue from contract termination in the quarter and $826 million year‑to‑date related to the Omnibus Agreement with CHI. Net income available to Tenet common shareholders reached $826 million for the quarter and $1,528 million for the first half, with diluted EPS of $9.84 and $17.81, respectively.
Cash from operating activities increased to $2,226 million in the first half of 2026, supporting capital spending of $348 million and share repurchases of $1,360 million, as Tenet bought back 7.021 million shares. Cash and cash equivalents were $2.170 billion at June 30, 2026, with long‑term debt of $13,248 million and full $1,900 million revolver availability.
Company THC filed a notice of proposed sales of common stock. The filing lists 10,000 common shares to be sold through Fidelity Brokerage Services LLC on July 29, 2026, with an aggregate market value of $2,580,295.03, while 86,137,000 shares are outstanding.
The disclosure also notes upcoming restricted stock vesting transactions: 2,953 common shares vesting on February 28, 2026 and 7,047 common shares vesting on March 1, 2026, both categorized as compensation from the issuer.
Tenet Healthcare Corp director Christopher S. Lynch reported selling 3,837 shares of Common Stock on July 27, 2026, in an open-market or private transaction at $243.44 per share. Following the sale, he directly owns 9,568 shares. The Rule 10b5-1 trading plan checkbox was not marked.
Tenet Healthcare Corp executive Paola M. Arbour, EVP and Chief Information Officer, sold 10,878 shares of common stock on July 27, 2026 in a transaction reported as a sale in open market or private transactions at a weighted average price of $243.90 per share, with individual prices ranging from $243.82 to $244.08. Following this sale, she directly holds 18,413 shares of Tenet Healthcare common stock. The transaction was not marked as made under a Rule 10b5-1 trading plan.